SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today its next-generation Dexcom G7 CGM System ...

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...

Dexcom G7 offers new features with a 60% smaller, discreet wearable patch. The Food and Drug Administration (FDA) has cleared the next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System ...

Dexcom's Stelo is not for individuals with low blood sugar as the system is not designed to alert the user to this condition. Stelo cleared for use without a prescription will provide an option for ...

BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (CGM), is happy to share that people with type 1 diabetes who are ...

Blood glucose giant Dexcom has used CES 2024 to announce a new continuous glucose monitor (CGM) designed specifically for Type 2 diabetics who don’t use insulin – Dexcom Stelo. The Stelo still ...

Dexcom G7 is available for people with all types of diabetes ages two years and older, giving more Canadians than ever access to a simple, accurate 1 and effective diabetes management solution BURNABY ...

Best Buy is set to offer a convenient way for eligible customers to get prescription continuous glucose monitoring systems delivered right to their home. Facilitated by Wheel, a leading virtual care ...

DexCom, Inc.'s (NASDAQ:DXCM) next-generation Dexcom G7 Continuous Glucose Monitoring System has been approved by Health Canada. This department operates under the Government of Canada and is ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor ...